Epigenetic progenitors in tumor initiation and development

Drug Discovery Today: Disease Models

Volumn 6, Issue 1, 2009, Pages 5-12

  Gao, Jian Xin ^a   Zhou, Quansheng ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; DNA; HISTONE DEACETYLASE; MYC PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PIWI PROTEIN; PROTEIN KINASE B; PROTEIN P53; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX3;

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DRUG RESEARCH; EPIGENETICS; GENE MUTATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRECANCER; REVIEW; RNA INTERFERENCE; STEM CELL; TUMOR GROWTH;

EID: 77949491803     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2009.01.001     Document Type: Review

References (94)

1. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
2. Gao J.X. Cancer stem cells: the lessons from precancerous stem cells. J. Cell Mol. Med. 12 (2008) 67-96
3. Kuukasjarvi T., et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57 (1997) 1597-1604
4. Kondo Y., and Issa J.P. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 23 (2004) 29-39
5. Feinberg A.P., et al. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7 (2006) 21-33
6. Morgan H.D., et al. Epigenetic reprogramming in mammals. Hum. Mol. Genet. 14 (2005) R47-58
7. Lafon-Hughes L., et al. Chromatin-remodelling mechanisms in cancer. Mutat. Res. 658 (2008) 191-214
8. Vaissiere T., et al. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 659 (2008) 40-48
9. Fog C.K., et al. Chromatin-modifying proteins in cancer. APMIS 115 (2007) 1060-1089
10. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
11. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 358 (2008) 1148-1159
12. Ushijima T. Epigenetic field for cancerization. J. Biochem. Mol. Biol. 40 (2007) 142-150
13. Gronbaek K., et al. Epigenetic changes in cancer. APMIS 115 (2007) 1039-1059
14. Sawan C., et al. Epigenetic drivers and genetic passengers on the road to cancer. Mutat. Res. 642 (2008) 1-13
15. Gal-Yam E.N., et al. Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med. 59 (2008) 267-280
16. Widschwendter M., et al. Epigenetic stem cell signature in cancer. Nat. Genet. 39 (2007) 157-158
17. Mullighan C.G., et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322 (2008) 1377-1380
18. Hong D., et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 319 (2008) 336-339
19. Chen L., et al. Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS ONE 2 (2007) e293
20. Damonte P., et al. Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Res. 10 (2008) R50
21. Lobo N.A., et al. The biology of cancer stem cells. Annu. Rev. Cell. Dev. Biol. 23 (2007) 675-699
22. Clarke M.F., et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res. 66 (2006) 9339-9344
23. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
24. Shen R., et al. Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3 (2008) e1652
25. Bussolati B., et al. Endothelial cell differentiation of human breast tumor stem/progenitor cells. J. Cell Mol. Med. (2008) (Epub ahead of print)
26. Wicha M.S. Cancer stem cells and metastasis: lethal seeds. Clin. Cancer Res. 12 (2006) 5606-5607
27. Donnenberg V.S., and Donnenberg A.D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J. Clin. Pharmacol. 45 (2005) 872-877
28. Huang E.H., et al. Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141 (2007) 415-419
29. Kelly P.N., et al. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
30. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
31. Armengol G., et al. Genetic evolution in the metastatic progression of human pancreatic cancer studied by CGH. Lab. Invest. 81 (2001) 1703-1707
32. Adams J.M., and Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones?. Cancer Res. 68 (2008) 4018-4021
33. Knudson A.G. Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol. 122 (1996) 135-140
34. Sporn M.B. Dichotomies in cancer research: some suggestions for a new synthesis. Nat. Clin. Pract. Oncol. 3 (2006) 364-373
35. Al-Hajj M., et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3983-3988
36. Singh S.K., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
37. O'Brien C.A., et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
38. Berman J.J., et al. Precancer: a conceptual working definition-results of a consensus conference. Cancer Detect. Prev. 30 (2006) 387-394
39. Cardiff R.D., et al. Precancer in mice: animal models used to understand, prevent, and treat human precancers. Toxicol. Pathol. 34 (2006) 699-707
40. Lee J.H., et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum. Mol. Genet. 15 (2006) 201-211
41. Gao, J.X. et al. (2008) (WO/2008/048570) PIWIL2-related biomarkers and cell lines useful therewith. (http://www.wipo.int/pctdb/en/wo.jsp?WO=2008048570) WO2008048570&DISPLAY=DESC
42. Werbowetski-Ogilvie T.E., and Bhatia M. Pluripotent human stem cell lines: what we can learn about cancer initiation. Trends Mol. Med. 14 (2008) 323-332
43. Tai M.H., et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26 (2005) 495-502
44. Mongan N.P., et al. The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol. Carcinog. 45 (2006) 887-900
45. Shen L., et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J. Natl. Cancer Inst. 97 (2005) 1330-1338
46. Giovannucci E., and Ogino S. DNA methylation, field effects, and colorectal cancer. J. Natl. Cancer Inst. 97 (2005) 1317-1319
47. Yan P.S., et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin. Cancer Res. 12 (2006) 6626-6636
48. Slaughter D.P., et al. 'Field cancerization' in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6 (1953) 963-968
49. Shen R., et al. Reversibility of aberrant global DNA and estrogen receptor-α gene methylation distinguishes the colorectal precancer from cancer. Int. J. Clin. Exp. Pathol. 2 (2009) 21-33
50. Cheng A.S.L., et al. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 68 (2008) 1786-1796
51. Fenton S.E. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147 (2006) s18-s24
52. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354 (2006) 270-282
53. Wong D.J., et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2 (2008) 333-344
54. Baylin S.B., et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10 (2001) 687-692
55. Esteller M. CpG island methylation and histone modifications: biology and clinical significance. Ernst Schering Res. Found. Workshop (2006) 115-126
56. Kanai Y., and Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28 (2007) 2434-2442
57. Jaronczyk K., et al. Exploring the functions of RNA interference pathway proteins: some functions are more RISCy than others?. Biochem. J. 387 (2005) 561-571
58. Dunn B.K. Hypomethylation: one side of a larger picture. Ann. N. Y. Acad. Sci. 983 (2003) 28-42
59. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
60. Weisenberger D.J., et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 33 (2005) 6823-6836
61. Baylin S.B., et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72 (1998) 141-196
62. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349 (2003) 2042-2054
63. Ekwall K. The RITS Complex - a direct link between small RNA and Heterochromatin. Mol. Cell 13 (2004) 304-305
64. Morris K.V., et al. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305 (2004) 1289-1292
65. Zardo G., et al. Dynamic and reversibility of heterochromatic gene silencing in human disease. Cell Res. 15 (2005) 679-690
66. Tagoh H., et al. Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible. EMBO J. 23 (2004) 4275-4285
67. Hendrix M.J., et al. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat. Rev. Cancer 7 (2007) 246-255
68. Osborne C., et al. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9 (2004) 361-377
69. Wood L.D., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113
70. Trent J.M., and Touchman J.W. Cancer: the gene topography of cancer. Science 318 (2007) 1079-1080
71. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
72. Ali I.U. Gatekeeper for endometrium: the PTEN tumor suppressor gene. J. Natl. Cancer Inst. 92 (2000) 861-863
73. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
74. Sasaki T., et al. Identification of eight members of the Argonaute family in the human genome small star, filled. Genomics 82 (2003) 323-330
75. Yin H., and Lin H. An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature 450 (2007) 304-308
76. Cox D.N., et al. A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev. 12 (1998) 3715-3727
77. Kuramochi-Miyagawa S., et al. Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development 131 (2004) 839-849
78. Lee J.H., et al. Stem cell protein Piwil2 modulates expression of murine spermatogonial stem cell expressed genes. Mol. Reprod. Dev. 73 (2006) 173-179
79. Deng W., and Lin H. miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis. Dev. Cell 2 (2002) 819-830
80. Kuramochi-Miyagawa S., et al. Two mouse piwi-related genes: miwi and mili. Mech. Dev. 108 (2001) 121-133
81. Carmell M.A., et al. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev. 16 (2002) 2733-2742
82. Liu J., et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (2004) 1437-1441
83. Dawe R.K. RNA interference on chromosomes. Nat. Genet. 36 (2004) 1141-1142
84. Folco H.D., et al. Heterochromatin and RNAi are required to establish CENP-A chromatin at centromeres. Science 319 (2008) 94-97
85. Tomari Y., et al. Sorting of Drosophila small silencing RNAs. Cell 130 (2007) 299-308
86. Buhler M., et al. Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-dependent gene silencing. Cell 125 (2006) 873-886
87. Qiao D., et al. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 21 (2002) 3988-3999
88. Aravin A., et al. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 442 (2006) 203-207
89. Aravin A.A., et al. Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 316 (2007) 744-747
90. Grivna S.T., et al. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev. 20 (2006) 1709-1714
91. Grivna S.T., et al. MIWI associates with translational machinery and PIWI-interacting RNAs (piRNAs) in regulating spermatogenesis. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 13415-13420
92. Lau N.C., et al. Characterization of the piRNA complex from rat testes. Science 313 (2006) 363-367
93. Saito K., et al. Specific association of Piwi with rasiRNAs derived from retrotransposon and heterochromatic regions in the Drosophila genome. Genes Dev. 20 (2006) 2214-2222
94. Brennecke J., et al. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 128 (2007) 1089-1103